Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Microarray-Based Diagnosis of Paediatric Hearing Impairment: Construction of a Deafness Gene Chip More
Monoclonal Antibody 3F5-5E5 and P107 Diagnostic Markers and Putative Vaccine Antigen for Moraxella Catarrhalis and Supplemental Mab 4G5 More
Single Ear Foetal Hearing Tester to Test Hearing Sensitivity of the Foetus at Each Ear More
Related Reports
Market Research Reports provided by reports.innovaro.com
Apr 2011 - 104 pages - $1,040
Mar 2011 - 94 pages - $1,040
Apr 2011 - 68 pages - $1,040
Apr 2011 - 68 pages - $1,040
Apr 2011 - 48 pages - $1,040
Apr 2011 - 72 pages - $1,040
Apr 2011 - 56 pages - $1,040
Apr 2011 - 64 pages - $1,040
Apr 2011 - 88 pages - $1,040
Apr 2011 - 74 pages - $1,040
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Aphthous ulcers
- Dental disorder (other)
- Gingivitis
- Gum disease
- Herpes simplex virus type 1 (oral)
- Mouth disorder (other)
- Mucositis oral
- Mucositis, Radiation-induced
- Periodontal disease
- Tooth decay
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us